Inactivation of genes TEC1 and EFG1 in Candida albicans influences extracellular matrix composition and biofilm morphology

References

• Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:1–11.
   Web of Science ®Google Scholar
• Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12:317–324.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–163.
   PubMed Web of Science ®Google Scholar
• Maurya V, Srivastava A, Mishra J, et al. Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India. J Infect Dev Ctries. 2013;7:608–613.
   Web of Science ®Google Scholar
• Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev. 2001;14:398–429.
   PubMed Web of Science ®Google Scholar
• Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res. 2007;86:204–215.
   PubMed Web of Science ®Google Scholar
• Abaci O, Haliki-Uztan A, Ozturk B, et al. Determining Candida spp. incidence in denture wearers. Mycopathologia. 2010;169:365–372.
   Web of Science ®Google Scholar
• Dağistan S, Aktas AE, Caglayan F, et al. Differential diagnosis of denture-induced stomatitis, Candida, and their variations in patients using complete denture: a clinical and mycological study. Mycoses. 2009;52:266–271.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Mitchell AP. Microbial biofilms: e pluribus unum. Curr Biol. 2007;17:R349–R353.
   PubMed Web of Science ®Google Scholar
• Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the “house of biofilm cells”. J Bacteriol. 2007;189:7945–7947.
   PubMed Web of Science ®Google Scholar
• Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.
   PubMed Web of Science ®Google Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017. PII:S1473-3099(17)30316-X.
   PubMed Web of Science ®Google Scholar
• Nett J, Lincoln L, Marchillo K, et al. Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 2007;51:510–520.
   PubMed Web of Science ®Google Scholar
• Vediyappan G, Rossignol T, d’Enfert C. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother. 2010;54:2096–2111.
   PubMed Web of Science ®Google Scholar
• Martins M, Uppuluri P, Thomas DP, et al. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia. 2010;169:323–331.
   PubMed Web of Science ®Google Scholar
• Zarnowski R, Westler WM, Lacmbouh GA, et al. Novel entries in a fungal biofilm matrix encyclopedia. MBio. 2014;5:e01333–e01314.
   PubMed Web of Science ®Google Scholar
• Ramage G, VandeWalle K, López-Ribot JL, et al. The filamentation pathway controlled by the EFG1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett. 2002;214:95–100.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol. 2005 21;15(12):1150–1155.
   PubMed Web of Science ®Google Scholar
• Stoldt VR, Sonneborn A, Leuker CE, et al. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. Embo J. 1997;16:1982–1991.
   PubMed Web of Science ®Google Scholar
• Schweizer A, Rupp S, Taylor BN, et al. The TEA/ATTS transcription factor Ca Tec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol. 2000;38:435–445.
   PubMed Web of Science ®Google Scholar
• Lo HJ, Köhler JR, DiDomenico B, et al. Nonfilamentous C. albicans mutants are avirulent. Cell. 1997;90:939–949.
   PubMed Web of Science ®Google Scholar
• Lewis RE, Lo H-J, Raad II, et al. Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother. 2002;46:1153–1155.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Fox EP, Nett JE, et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012;148:126–138.
   PubMed Web of Science ®Google Scholar
• Koo H, Hayacibara MF, Schobel BD, et al. Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. J Antimicrob Chemother. 2003;52:782–789.
   PubMed Web of Science ®Google Scholar
• Dubois M, Gilles KA, Hamilton JK, et al. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28:350–356.
   Web of Science ®Google Scholar
• Rice KC, Mann EE, Endres JL, et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA. 2007;104:8113–8118.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Weber K, Delben J, Bromage TG, et al. Comparison of SEM and VPSEM imaging techniques with respect to Streptococcus mutans biofilm topography. FEMS Microbiol Lett. 2014;350:175–179.
   Web of Science ®Google Scholar
• Delben JA, Zago CE, Tyhovych N, et al. Effect of atmospheric-pressure cold plasma on pathogenic oral biofilms and in vitro reconstituted oral epithelium. PLoS One. 2016;11:e0155427.
   PubMed Web of Science ®Google Scholar
• Heydorn A, Nielsen AT, Hentzer M, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology. 2000;146:2395–2407.
   PubMed Web of Science ®Google Scholar
• Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–633.
   PubMed Web of Science ®Google Scholar
• Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol. 2006;9(6):588–594.
   PubMed Web of Science ®Google Scholar
• Ramage G, Rajendran R, Sherry L, et al. Fungal biofilm resistance. Int J Microbiol. 2012;2012:1–14.
   Google Scholar
• Hirota K, Yumoto H, Sapaar B, et al. Pathogenic factors in Candida biofilm-related infectious diseases. J Appl Microbiol. 2017;122:321–330.
   Web of Science ®Google Scholar
• Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol. 2011;9:109–118.
   PubMed Web of Science ®Google Scholar
• Pierce JV, Dignard D, Whiteway M, et al. Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes. Eukaryot Cell. 2013;12:37–49.
   PubMed Web of Science ®Google Scholar
• Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol. 2006;55:999–1008.
   PubMed Web of Science ®Google Scholar
• Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother. 2000;46:397–403.
   PubMed Web of Science ®Google Scholar
• Taff HT, Nett JE, Zarnowski R, et al. A Candida biofilm induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012;8:e1002848.
   PubMed Web of Science ®Google Scholar
• Xie Z, Thompson A, Sobue T, et al. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis. 2012;206:1936–1945.
   PubMed Web of Science ®Google Scholar
• Nett JE, Crawford K, Marchillo K, et al. Role of fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother. 2010;54:3505–3508.
   PubMed Web of Science ®Google Scholar
• Nett JE, Sanchez H, Cain MT, et al. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis. 2010;202:171–175.
   PubMed Web of Science ®Google Scholar
• Prasad T, Hameed S, Manoharlal R, et al. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res. 2010;10:587–596.
   PubMed Web of Science ®Google Scholar
• Bink A, Govaert G, Vandenbosch D, et al. Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo. J Med Microbiol. 2012;61:813–819.
   Web of Science ®Google Scholar
• Nur A, Hirota K, Yumoto H, et al. Effects of extracellular DNA and DNA-binding protein on the development of a Streptococcus intermedius biofilm. J Appl Microbiol. 2013;115:260–270.
   PubMed Web of Science ®Google Scholar
• Sapaar B, Nur A, Hirota K, et al. Effects of extracellular DNA from Candida albicans and pneumoniarelated pathogens on Candida biofilm formation and hyphal transformation. J Appl Microbiol. 2014;116:1531–1542.
   PubMed Web of Science ®Google Scholar
• Martins M, Henriques M, Lopez-Ribot JL, et al. Addition of DNAse improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses. 2012;55:80–85.
   PubMed Web of Science ®Google Scholar
• Rajendran R, Sherry L, Lappin DF, et al. Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation. BMC Microbiol. 2014;14:303.
   PubMed Web of Science ®Google Scholar
• Peters BM, Palmer GE, Nash AK, et al. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect Immun. 2014;82:532–543.
   PubMed Web of Science ®Google Scholar
• Pierce JV, Kumamotoa CA. Variation in Candida albicans EFG1 expression enables host-dependent changes in colonizing fungal populations. mBio. 2012;3:e00117–e00112.
   PubMed Web of Science ®Google Scholar
• Branda SS, Vik Å, Friedman L, et al. Biofilms: the matrix revisited. Trends Microbiol. 2005;13:20–26.
   PubMed Web of Science ®Google Scholar
• Branda SS, Chu F, Kearns DB, et al. A major protein component of the Bacillus subtilis biofilm matrix. Mol Microbiol. 2006;59:1229–1238.
   PubMed Web of Science ®Google Scholar
• Thomas DP, Bachmann SP, Lopez-Ribot JL. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics. 2006;6:5795–5804.
   PubMed Web of Science ®Google Scholar
• Martínez-Gomariz M, Perumal P, Mekala S, et al. Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics. 2009;9:2230–2252.
   PubMedGoogle Scholar
• Nobile CJ, Nett JE, Hernday AD, et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 2009;7:e1000133.
   PubMed Web of Science ®Google Scholar